3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Prostatic Neoplasms
18
Neoplasms
18
Breast Neoplasms
16
Colorectal Neoplasms
12
Carcinoma, Non-Small-Cell Lung
11
Lung Neoplasms
10
Urinary Bladder Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
6
Hematopoietic and Lymphatic System Neoplasm
6
Hematologic Neoplasms
6
Ovarian Neoplasms
5
Neoplasm Metastasis
5
Triple Negative Breast Neoplasms
4
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Mouth Neoplasms
3
Hematopoietic and Lymphoid System Neoplasm
3
Head and Neck Neoplasms
3
Fallopian Tube Neoplasms
3
Carcinoma, Renal Cell
3
Sarcoma
2
Radiodermatitis
2
Peritoneal Neoplasms
2
Pathologic Complete Response
2
Parotid Neoplasms
2
Motor Activity
2
Melanoma
2
Malignant Solid Neoplasm
2
Interventions
Temozolomide
6
Cyclophosphamide
5
cabozantinib
4
Vincristine
4
fludarabine
3
Radiotherapy
3
Irinotecan
3
liposomal doxorubicin
2
irinotecan sucrosofate
2
Zoledronic Acid
2
Topotecan
2
Specimen Handling
2
PM 01183
2
Ifosfamide
2
Etoposide
2
Eflornithine
2
Drug Therapy
2
Doxorubicin
2
trilaciclib
1
trifluridine tipiracil drug combination
1
talazoparib
1
silmitasertib
1
romiplostim
1
regorafenib
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
naxitamab
1
fluzoparib
1
fludarabine phosphate
1
X-Rays
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Sarcoma, Ewing
×
Standard of Care
×
Clear all
NCT04055220
2026-02-17
REGOSTA
Centre Leon Berard
Phase NA
Recruiting
168 enrolled